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Sthe left common carotid artery can be performed if the
left subclavian artery is involved. It is also used for long
segment disease. Patch ostioplasty is ideal for an iso-
lated ostial LIMA lesion not involving the left subclavian
artery [6].
High serum levels of circulating low-density lipopro-
tein are deposited on the aortic valve. Secondary changes
such as calciﬁcation and inﬂammation lead to develop-
ment of severe calciﬁc aortic stenosis, sometimes
extending to the mitral valve. Usually disease starts much
earlier in life when the aortic root is small. Deposition of
calcium along with deformed growth of the aortic root
will cause a small aortic root, posing problems for aortic
valve replacement. Often, the root-enlarging procedure is
required to ﬁt in an adequately sized valve [7].
The ﬁrst operation was performed and reported by Dr Anil Bhan,
formerly a Professor at our institute.
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An infrequent but devastating late complication of Fon-
tan circulation is protein-losing enteropathy (PLE), which
results from unbalanced lymphatic homeostasis. Surgical 2016 by The Society of Thoracic Surgeons
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For personal use only. No other uses without permission.decompression of the thoracic duct by redirecting its
drainage to the pulmonary venous atrium has been
introduced recently as a possible treatment. This report
describes a single-institution experience with this inno-
vative procedure in 2 patients with failing Fontan circu-
lation with PLE refractory to optimized medical therapy.
(Ann Thorac Surg 2016;101:2370–3)
 2016 by The Society of Thoracic Surgeons
ince 1968, palliation of functional single ventricles hasSundergone many revisions to improve survival and
decrease long-term morbidity. Fontan circulation now
encompasses a spectrum of anatomical substrates, stag-
ing options, and operative techniques [1, 2]. Inherent to
this circulation model is the absence of a dedicated power
source to serve the pulmonary circulation and, conse-
quently, chronic elevation of central venous pressure
(CVP). This will unbalance lymphatic homeostasis, lead-
ing to ﬂuid accumulation [2, 3]. Lymphatic insufﬁciency
has a central role in the disease process of 1 of the most
devastating complications of Fontan procedures—pro-
tein-losing enteropathy (PLE) [4, 5]. To improve lym-
phatic drainage, a new surgical concept based on
decompression of the thoracic duct to the lower pressure
levels of the systemic atrium was recently introduced [3].
We describe our experience with this innovative pro-
cedure in 2 patients with PLE refractory to optimized
medical therapy for their failing Fontan circulation.Case Reports
Patient 1
A 17-year-old boy with hypoplastic left heart syndrome
underwent neonatal Norwood palliation followed by a
bidirectional cavopulmonary anastomosis at 9 months of
age and Fontan completion through a fenestrated
extracardiac conduit at 3 years of age. The last operation
was complicated by third-degree atrioventricular block
treated by double-chamber epicardial pacing. Eleven
years later his exercise capacity deteriorated, with severe
heart failure, ascites, and hypoalbuminemia. Cardiac
catheterization showed an unobstructed Fontan pathway
with a mean pressure of 18 mm Hg in the main pulmo-
nary artery; the fenestration was patent and there was no
systemic outﬂow tract obstruction. Pulmonary vasodilator
therapy achieved only slight improvement. Two years
later, he underwent replacement of his pacemaker system
and subsequently experienced progressive hypo-
albuminemia, hypoproteinemia, and ascites despite
aggressive medical therapy and multiple albumin trans-
fusions. He was listed for heart transplantation, but
because of successive positive cross-matches, the patient
began a pretransplantation desensitization program with
rituximab and bortezomib. Forty-eight hours after the0003-4975/$36.00
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Fig 1. Computed tomographic
(CT) angiography shows patent
innominate vein–to-atrium
conduit.
Table 1. Comparison of Clinical Data Before and After
Operation
Clinical Data
Patient 1
Before Operation/
After Operation
Patient 2
Before Operation/
After Operation
Serum albumin 28 g/L >35 g/L 18 g/L >35 g/L
Ascites Severe Mild Severe Mild
Facial edema . . . . . . Moderate Mild
Arterial saturation 94% 88% 99% 94%
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Sﬁrst drug cycle, he experienced vasoplegic septic shock.
Despite 2 months of aggressive medical therapy and
weekly paracentesis, his clinical status did not improve,
and he was unable to be weaned from intravenous
inotropic agents. Being at a therapeutic impasse, surgical
decompression of the thoracic duct was performed by
diverting the innominate vein to the atrium through an
8-mm Gore-Tex (W. L. Gore Associates, Flagstaff, AZ)
graft. Ascites continued for another 5 weeks but then
progressively resolved with signiﬁcant clinical improve-
ment. He was discharged 7 weeks after the operation but
later presented with facial edema. Computed tomo-
graphic angiography (CT angiography) revealed a patent
innominate-atrial anastomosis (Fig 1). By 10 months after
the surgical procedure, he was weaned from corticoste-
roids, with complete resolution of facial edema, a normal
serum albumin level, arterial saturation of 88%, and only
mild ascites (Table 1). Clinically, the patient remains
dramatically improved and his condition is stable.
Patient 2
A 15-year-old girl with a 9-year history of PLE underwent
the same operation while awaiting transplantation for her
failing Fontan circulation. Born with a double-inlet leftDownloaded from ClinicalKey.com at Centro 
For personal use only. No other uses without permission.ventricle, transposition of the great arteries, and coarcta-
tion of the aorta, she underwent coarctation repair and
pulmonary artery banding in the neonatal period, followed
by a Damus-Kaye-Stansel anastomosis and bidirectional
cavopulmonary anastomosis 8 months later. At 3 years of
age, the Fontan circulation was completed by a fenestrated
extracardiac conduit. This was complicated by third-
degree atrioventricular block, which was treated by
double-chamber epicardial pacing. Twelve years later she
experienced severe ascites, facial edema, and persistent
hypoalbuminemia; Fontan pathway mean pressure was 15
mm Hg at cardiac catheterization, but there was sluggishHospitalar Lisboa Central May 24, 2016.
 Copyright ©2016. Elsevier Inc. All rights reserved.
Fig 2. Computed tomographic
(CT) angiography shows
completely occluded innominate
vein–to-atrium conduit.
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Sﬂow in the inferior vena cava, and the fenestration was not
patent. She had no systemic outﬂow tract obstruction.
Aggressive medical therapy with 2 pulmonary vasodila-
tors, low-molecular-weight heparin, selective oral cortico-
steroids, multiple albumin transfusions, and intravenous
diuretics did not improve her clinical status signiﬁcantly
despite a slight improvement in albumin levels. Thoracic
duct diversion was complicated by right pleural effusion,
but she was discharged 4 weeks later. Control CT angi-
ography 4 months later revealed complete occlusion of the
innominate-atrial anastomosis (Fig 2). At last follow-up 6
months after the surgical procedure, the patient was still
receiving oral corticosteroids, arterial saturation ranged
from 94% to 95%, and both ascites and facial edema had
improved (Table 1). She remains hemodynamically stable
with normal serum albumin and protein levels and no
recurrence of pleural effusions.Fig 3. Interposition of prosthetic conduit (8-mm Gore-Tex graft)
between the innominate vein and the atrium. (CA ¼ common atrium;
IV ¼ innominate vein; IVC ¼ inferior vena cava; SVC ¼ superior
vena cava; TD ¼ thoracic duct.)Comment
Management of late Fontan complications, particularly
PLE, remains challenging. This secondary disorder is
characterized by profound loss of serum proteins into the
gastrointestinal lumen caused by enteric mucosal injury,
systemic inﬂammation, and venous or lymphatic
obstruction [4].
The relative infrequency of PLE, combined with our
rudimentary knowledge of the interplay between the
cardiovascular and lymphatic systems, has hindered un-
derstanding of the pathophysiologic processes underly-
ing this disease, as well as the development of effective
therapy. Transplantation is often the only reasonable
option [5, 6]. Historically, survival after diagnosis has
been 50% at 5 years [4, 7]. Nevertheless, a recent study
reported 88% and 72% survival rates at 5 and 10 years,
respectively, after diagnosis. This markedly improved
survival may reﬂect earlier diagnosis from routine
screening [8].
Supportive evidence suggests that the lymphatic sys-
tem operates at or near its physiologic limit in patients
with Fontan circulation [5, 7]. Inherent to this circulationDownloaded from ClinicalKey.com at Centro 
For personal use only. No other uses without permission.are passive pulmonary blood ﬂow and elevated CVP,
which is transmitted backward to the hepatic and intes-
tinal venous system. This causes increased lymph pro-
duction, for which the lymphatic pump cannot
compensate. In addition, chronic elevation of CVP retards
lymphatic return to the central venous system, thus
unbalancing lymphatic homeostasis [2–5]. The procedure
of thoracic duct decompression was introduced to un-
burden the thoracic duct and increase the transport ca-
pacity of the lymphatic system. This should improve not
only the systemic venous congestion but also preload of
the single ventricle, and therefore cardiac output at the
expense of mild desaturation consequent to a right-to-leftHospitalar Lisboa Central May 24, 2016.
 Copyright ©2016. Elsevier Inc. All rights reserved.
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Sshunt [3]. Both the concept and the technique of diverting
the innominate vein into the lower-pressure atrium are
simple. Ideally, the largest possible direct anastomosis is
preferred. However, taking into consideration that our
patients had several redo operations, this fact creates
challenging scenarios making it safer to interpose a
prosthetic conduit because of length and technical difﬁ-
culties (Fig 3). Although this not be the ideal, it may work
equally well.
Our experience with this procedure in 2 patients with
failing Fontan circulation who had been listed for heart
transplantation suggests that 3 to 4 weeks are necessary to
achieve normal serum albumin levels and improved
clinical status. Arterial desaturation was acceptable after
the operation. Despite receiving therapeutic low-
molecular-weight heparin and platelet aggregate in-
hibitors, the innominate vein–to-atrium conduit occluded
in 1 patient. Nevertheless, her serum albumin levels and
clinical status remained improved, suggesting that some
degree of lymphatic decompression, possibly through
development of venous collaterals, may still have taken
place. The conduit is patent in the other patient 10
months after the operation; he is receiving anti-
coagulation therapy with warfarin.
Although we have not yet performed transplantation in
either of these patients (this being 1 of the merits of this
procedure), we do not anticipate additional technical
difﬁculties. We will either leave the connection closed,
hoping that the acquired collateralization will make
pressures in the system low (which can be easily
measured on completion of the transplantation proce-
dure), or conduit reconstruction to the superior vena cava
system will be considered. Having said this, the status
created by a full normal heart and circulation will be
sufﬁcient to deal with an eventual increase in the
lymphatic drainage; however, this will have to be
conﬁrmed.
In conclusion, thoracic duct decompression for PLE is
based on physiologic principles. It is technically a simple
procedure despite being a reoperation. Global experience
is still limited, but early results in a small number of
patients have been encouraging. More experience is
needed to conﬁrm these results, elucidate optimal
methods of postoperative anticoagulation, and improve
understanding of the underlying pathophysiologic char-
acteristics. Modiﬁcations of surgical technique may also
offer an opportunity for improved patency of the
lymphatic-to-venous connection.
The authors wish to thank Professor Viktor Hraska for advice
regarding the management of these patients, Professor Roxane
Mckay for her help in preparing the manuscript, and Dr Alvaro
Laranjeira for his help with the surgical drawing.
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Hemoglobin SC (HbSC) disease is a hemoglobinopathy
that may produce sickling under conditions of hypox-
emia, dehydration, and acidosis. We present a case of
HbSC disease and tricuspid atresia, type IB. We describe
management by cardiopulmonary bypass CPB using ex-
change transfusion at initiation of bypass and fraction-
ation of collected blood, allowing platelet and plasma
apheresis, as an option for patients unable to undergo
this procedure off pump.
(Ann Thorac Surg 2016;101:2373–5)
 2016 by The Society of Thoracic Surgeons
emoglobin SC (HbSC) disease is a hemoglobinop-Hathy deﬁned by abnormal HbS and HbC in a 50:50
ratio in the erythrocyte [1]. HbC is produced by a genetic
mutation causing upregulation of the potassium chloride
cotransporter, increasing potassium efﬂux from erythro-
cytes and producing cell dehydration [1]. The combina-
tion of dehydration and HbS polymerization is
responsible for the clinical manifestations of HbSC dis-
ease, including pain crises, acute chest syndrome, splenic0003-4975/$36.00
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